1. Resources and Training
  2. Haematology
  3. Product resources and training
  4. Haematology Academy

Haematology

_

With more than 20 years’ experience in haematology, Novartis is dedicated to continued research, innovation and treatment support.

That’s why we have created the Haematology Academy. It’s a collection of resources that is made with healthcare professionals in mind. Here, you can quickly access information and find out more about our progressive portfolio of treatments.

 

Select one of our treatments to access information that can help you with your day-to-day practice.

RYDAPT® prescribing information

TASIGNA® prescribing information

JAKAVI® prescribing information

EXJADE® prescribing information

REVOLADE® prescribing information

Rate this content: 
No votes yet
HCP20-C030 July 2020.
Haematology
Product resource
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]